Advertisement

Non-Eosinophilic Granulomatous Disease and the Unified Airway

  • Joanne Rimmer
    Correspondence
    Corresponding author. Department of Otolaryngology Head & Neck Surgery, ENT Building, Moorabbin Hospital, 823-865 Centre Road, Bentleigh East, Victoria 3165, Australia.
    Affiliations
    Department of Surgery, Monash University, Monash Medical Centre Level 5, Block E, 246 Clayton Road, Clayton, 3168 VIC, Australia

    Department of Otolaryngology Head & Neck Surgery, Monash Health, ENT Building, Moorabbin Hospital, 823-865 Centre Road, Bentleigh East, VIC 3165, Australia

    Department of Otolaryngology Head & Neck Surgery, St Vincent’s Hospital, 41 Victoria Parade, Fitzroy, VIC 3065, Australia
    Search for articles by this author
  • Valerie J. Lund
    Affiliations
    Royal National Ear, Nose and Throat and Eastman Dental Hospitals, 47-49 Huntley St, London WC1E 6DG, UK

    University College London Ear Institute, 332 Grays Inn Rd, London WC1X 8EE, UK
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Otolaryngologic Clinics of North America
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jennette J.C.
        • Falk R.J.
        • Bacon P.A.
        • et al.
        2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.
        Arthritis Rheum. 2013; 65: 1-11
        • Ross C.
        • Makhzoum J.P.
        • Pagnoux C.
        Updates in ANCA-associated vasculitis.
        Eur J Rheumatol. 2022; https://doi.org/10.5152/eujrheum.2022.20248
        • Stone J.H.
        • Wegener's Granulomatosis Etanercept Trial Research Group
        Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
        Arthritis Rheum. 2003; 48: 2299-2309
        • Leavitt R.Y.
        • Fauci A.S.
        • Bloch D.A.
        • et al.
        The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis.
        Arthritis Rheum. 1990; 33: 1101-1107
        • Robson J.C.
        • Grayson P.C.
        • Ponte C.
        • et al.
        2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.
        Ann Rheum Dis. 2022; 81: 315-320
        • Fokkens W.J.
        • Lund V.J.
        • Hopkins C.
        • et al.
        European position paper on rhinosinusitis and nasal polyps 2020.
        Rhinology. 2020; 29: 1-464
        • Srouji I.A.
        • Andrews P.
        • Edwards C.
        • et al.
        Patterns of presentation and diagnosis of patients with Wegener's granulomatosis: ENT aspects.
        J Laryngol Otol. 2007; 121: 653-658
        • Kühn D.
        • Hospowsky C.
        • Both M.
        • et al.
        Manifestation of granulomatosis with polyangiitis in head and neck.
        Clin Exp Rheumatol. 2018; 36: 78-84
        • Felicetti M.
        • Cazzador D.
        • Padoan R.
        • et al.
        Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes.
        Clin Rheumatol. 2018; 37: 1075-1083
        • Puéchal X.
        • Iudici M.
        • Pagnoux C.
        • et al.
        • French Vasculitis Study Group
        Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry.
        RMD Open. 2022; 8: e002160
        • Trimarchi M.
        • Bertazzoni G.
        • Bussi M.
        Cocaine induced midline destructive lesions.
        Rhinology. 2014; 52: 104-111
        • Lloyd G.
        • Lund V.J.
        • Beale T.
        • et al.
        Rhinologic changes in Wegener’s granulomatosis.
        J Laryngol Otol. 2002; 116: 565-569
        • D'Anza B.
        • Langford C.A.
        • Sindwani R.
        Sinonasal imaging findings in granulomatosis with polyangiitis (Wegener granulomatosis): A systematic review.
        Am J Rhinol Allergy. 2017; 31: 16-21
        • Borner U.
        • Landis B.N.
        • Banz Y.
        • et al.
        Diagnostic value of biopsies in identifying cytoplasmic antineutrophil cytoplasmic antibody-negative localized Wegener's granulomatosis presenting primarily with sinonasal disease.
        Am J Rhinol Allergy. 2012; 26: 475-480
        • Masiak A.
        • Zdrojewski Z.
        • Peksa R.
        • et al.
        The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis.
        Reumatologia. 2017; 5: 230-236
        • Yates M.
        • Watts R.A.
        • Bajema I.M.
        • et al.
        EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
        Ann Rheum Dis. 2016; 75: 1583-1594
        • Stone J.H.
        • Merkel P.A.
        • Spiera R.
        • et al.
        • RAVE-ITN Research Group
        Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
        N Engl J Med. 2010; 363: 221-232
        • Jones R.B.
        • Tervaert J.W.
        • Hauser T.
        • et al.
        European Vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
        N Engl J Med. 2010; 363: 211-220
        • Jayne D.R.W.
        • Merkel P.A.
        • Schall T.J.
        • et al.
        • ADVOCATE Study Group
        Avacopan for the Treatment of ANCA-Associated Vasculitis.
        N Engl J Med. 2021; 384: 599-609
        • Guillevin L.
        • Pagnoux C.
        • Karras A.
        • et al.
        • French Vasculitis Study Group
        Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
        N Engl J Med. 2014; 371: 1771-1780
        • Smith R.
        • Jayne D.
        • Merkel P.
        A randomized, controlled trial of rituximab versus azathioprine after induction of remission with rituximab for patients with ANCA-associated Vvsculitis and relapsing disease [abstract].
        Arthritis Rheumatol. 2019; 71 (Available at:) (Accessed May 11, 2022)
        • Cannady S.B.
        • Batra P.S.
        • Koening C.
        • et al.
        Sinonasal Wegener granulomatosis: A single-institution experience with 120 cases.
        Laryngoscope. 2009; 119: 757-761
        • Erickson V.R.
        • Hwang P.H.
        Wegenerʼs granulomatosis: current trends in diagnosis and management.
        Curr Opin Otolaryngol Head Neck Surg. 2007; 15: 170-176
        • Ezzat W.H.
        • Compton R.A.
        • Basa K.C.
        • et al.
        Reconstructive techniques for the saddle nose deformity in granulomatosis with polyangiitis: a systematic review.
        JAMA Otolaryngol Head Neck Surg. 2017; 143: 507-512
        • Nouraei S.A.
        • Obholzer R.
        • Ind P.W.
        • et al.
        Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener’s granulomatosis.
        Thorax. 2008; 63: 49-52
        • Takagi D.
        • Nakamaru Y.
        • Maguchi S.
        • et al.
        Otologic manifestations of Wegener’s granulomatosis.
        Laryngoscope. 2002; 112: 1684-1690
        • Alobid I.
        • Guilemany J.M.
        • Mullol J.
        Nasal manifestations of systemic illnesses.
        Curr Allergy Asthma Rep. 2004; 4: 208-216
        • Schupp J.C.
        • Freitag-Wolf S.
        • Bargagli E.
        • et al.
        Phenotypes of organ involvement in sarcoidosis.
        Eur Respir J. 2018; 51: 1700991
        • Morgenthau A.S.
        • Teirstein A.S.
        Sarcoidosis of the upper and lower airways.
        Expert Rev Respir Med. 2011; 5: 823-833
        • Reed J.
        • deShazo R.D.
        • Houle T.T.
        • et al.
        Clinical features of sarcoid rhinosinusitis.
        Am J Med. 2010; 123: 856-862
        • Judson M.A.
        The clinical features of sarcoidosis: a comprehensive review.
        Clin Rev Allergy Immunol. 2015; 49: 63-78
        • Wilson R.
        • Lund V.
        • Sweatman M.
        • et al.
        Upper respiratory tract involvement in sarcoidosis and its management.
        Eur Respir J. 1988; 1: 269-272
        • Millward K.
        • Fiddler C.A.
        • Thillai M.
        Update on sarcoidosis guidelines.
        Curr Opin Pulm Med. 2021; 27: 484-489
        • Thillai M.
        • Atkins C.P.
        • Crawshaw A.
        • et al.
        BTS Clinical Statement on pulmonary sarcoidosis.
        Thorax. 2021; 76: 4-20
        • Joshi R.
        • Zenga J.
        • Getz A.
        • et al.
        THU0403 Sinonasal sarcoidosis: Review of clinical and imaging features: 7 year experience.
        Ann Rheum Dis. 2013; 71: 291-292
        • Scadding J.G.
        Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation.
        Br Med J. 1961; 2: 1165-1172
        • Ho J.S.Y.
        • Chilvers E.R.
        • Thillai M.
        Cardiac sarcoidosis - an expert review for the chest physician.
        Expert Rev Respir Med. 2019; 13: 507-520
        • Crouser E.D.
        • Lozanski G.
        • Fox C.C.
        • et al.
        The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy.
        Chest. 2010; 137: 1432-1435
        • Aloulah M.
        • Manes R.P.
        • Ng Y.H.
        • et al.
        Sinonasal manifestations of sarcoidosis: a single institution experience with 38 cases.
        Int Forum Allergy Rhinol. 2013; 3: 567-572
        • Kay D.J.
        • Har-El G.
        The role of endoscopic sinus surgery in chronic sinonasal sarcoidosis.
        Am J Rhinol. 2001; 15: 249-254